Thiem D Phan
Examiner (ID: 7633)
Most Active Art Unit | 3729 |
Art Unit(s) | 3729 |
Total Applications | 2341 |
Issued Applications | 1787 |
Pending Applications | 105 |
Abandoned Applications | 401 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12813094
[patent_doc_number] => 20180162868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 15/600612
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 129268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600612
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600612 | BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS | May 18, 2017 | Abandoned |
Array
(
[id] => 18233419
[patent_doc_number] => 11597968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-07
[patent_title] => Ribonucleic acid (RNA) interactions
[patent_app_type] => utility
[patent_app_number] => 16/300664
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25071
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 210
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300664
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/300664 | Ribonucleic acid (RNA) interactions | May 11, 2017 | Issued |
Array
(
[id] => 12580662
[patent_doc_number] => 20180085383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 15/590107
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19221
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15590107
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/590107 | SMALL MOLECULE CD38 INHIBITORS AND METHODS OF USING SAME | May 8, 2017 | Abandoned |
Array
(
[id] => 14868709
[patent_doc_number] => 20190284596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => STOICHIOMETRIC NUCLEIC ACID PURIFICATION USING RANDOMER CAPTURE PROBE LIBRARIES
[patent_app_type] => utility
[patent_app_number] => 16/099359
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099359
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099359 | Stoichiometric nucleic acid purification using randomer capture probe libraries | May 4, 2017 | Issued |
Array
(
[id] => 11880661
[patent_doc_number] => 09751821
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-09-05
[patent_title] => 'Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound and method for production of isoxazoline compound'
[patent_app_type] => utility
[patent_app_number] => 15/586913
[patent_app_country] => US
[patent_app_date] => 2017-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51847
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15586913
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/586913 | Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound and method for production of isoxazoline compound | May 3, 2017 | Issued |
Array
(
[id] => 14700023
[patent_doc_number] => 10377745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-13
[patent_title] => Heterocyclic compounds as NaV channel inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/584487
[patent_app_country] => US
[patent_app_date] => 2017-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 30732
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15584487
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/584487 | Heterocyclic compounds as NaV channel inhibitors and uses thereof | May 1, 2017 | Issued |
Array
(
[id] => 12022146
[patent_doc_number] => 20170312246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-02
[patent_title] => 'LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR USE IN THE TREATMENT OF ATROPHIC VAGINITIS'
[patent_app_type] => utility
[patent_app_number] => 15/499419
[patent_app_country] => US
[patent_app_date] => 2017-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11907
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15499419
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/499419 | LIPIDIC FURAN, PYRROLE, AND THIOPHENE COMPOUNDS FOR USE IN THE TREATMENT OF ATROPHIC VAGINITIS | Apr 26, 2017 | Abandoned |
Array
(
[id] => 12448314
[patent_doc_number] => 09981956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Small molecule inhibitors of fibrosis
[patent_app_type] => utility
[patent_app_number] => 15/488206
[patent_app_country] => US
[patent_app_date] => 2017-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 34
[patent_no_of_words] => 36207
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15488206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/488206 | Small molecule inhibitors of fibrosis | Apr 13, 2017 | Issued |
Array
(
[id] => 14375747
[patent_doc_number] => 20190161786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-30
[patent_title] => METHODS FOR SELECTING ENZYMES HAVING PROTEASE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/091765
[patent_app_country] => US
[patent_app_date] => 2017-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20774
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16091765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/091765 | METHODS FOR SELECTING ENZYMES HAVING PROTEASE ACTIVITY | Apr 6, 2017 | Abandoned |
Array
(
[id] => 16591718
[patent_doc_number] => 10900974
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-26
[patent_title] => Methods for identifying macromolecule interactions
[patent_app_type] => utility
[patent_app_number] => 15/466861
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 39
[patent_no_of_words] => 24464
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15466861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/466861 | Methods for identifying macromolecule interactions | Mar 21, 2017 | Issued |
Array
(
[id] => 14145271
[patent_doc_number] => 10252993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-09
[patent_title] => Crystalline form of atorvastatin hemi-calcium salt, hydrate thereof, and method of producing the same
[patent_app_type] => utility
[patent_app_number] => 15/441430
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 3139
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15441430
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/441430 | Crystalline form of atorvastatin hemi-calcium salt, hydrate thereof, and method of producing the same | Feb 23, 2017 | Issued |
Array
(
[id] => 11668371
[patent_doc_number] => 20170157092
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'Anti-depression Compounds'
[patent_app_type] => utility
[patent_app_number] => 15/440396
[patent_app_country] => US
[patent_app_date] => 2017-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 72
[patent_figures_cnt] => 72
[patent_no_of_words] => 139033
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15440396
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/440396 | Anti-depression compounds | Feb 22, 2017 | Issued |
Array
(
[id] => 13251081
[patent_doc_number] => 10138219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-27
[patent_title] => Methods and compounds for restoring mutant p53 function
[patent_app_type] => utility
[patent_app_number] => 15/436333
[patent_app_country] => US
[patent_app_date] => 2017-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 41173
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 594
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15436333
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/436333 | Methods and compounds for restoring mutant p53 function | Feb 16, 2017 | Issued |
Array
(
[id] => 16284049
[patent_doc_number] => 20200277651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => Nucleic Acid Preparation and Analysis
[patent_app_type] => utility
[patent_app_number] => 15/998587
[patent_app_country] => US
[patent_app_date] => 2017-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15998587
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/998587 | Nucleic Acid Preparation and Analysis | Feb 15, 2017 | Abandoned |
Array
(
[id] => 11668414
[patent_doc_number] => 20170157134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'COMBINATION THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/433392
[patent_app_country] => US
[patent_app_date] => 2017-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11769
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15433392
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/433392 | COMBINATION THERAPY | Feb 14, 2017 | Abandoned |
Array
(
[id] => 13868379
[patent_doc_number] => 20190030530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => MICRO- AND NANOCONTACT PRINTING WITH AMINOSILANES: PATTERNING SURFACES OF MICROFLUIDIC DEVICES FOR MULTI- PLEXED BIOASSAYS
[patent_app_type] => utility
[patent_app_number] => 16/073791
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/073791 | MICRO- AND NANOCONTACT PRINTING WITH AMINOSILANES: PATTERNING SURFACES OF MICROFLUIDIC DEVICES FOR MULTI- PLEXED BIOASSAYS | Jan 31, 2017 | Abandoned |
Array
(
[id] => 11627440
[patent_doc_number] => 20170137629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'Laundry Care Compositions Containing Dyes'
[patent_app_type] => utility
[patent_app_number] => 15/421621
[patent_app_country] => US
[patent_app_date] => 2017-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22544
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15421621
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/421621 | Laundry Care Compositions Containing Dyes | Jan 31, 2017 | Abandoned |
Array
(
[id] => 11827605
[patent_doc_number] => 09724334
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2017-08-08
[patent_title] => 'Method for treating a neurodegenerative disease or depression comprising administering derivatives of 2-amino-2-(1-dodecyl-1H-1,2,3-triazol-4-yl)propane-1,3-diol'
[patent_app_type] => utility
[patent_app_number] => 15/417315
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 24
[patent_no_of_words] => 6305
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417315
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417315 | Method for treating a neurodegenerative disease or depression comprising administering derivatives of 2-amino-2-(1-dodecyl-1H-1,2,3-triazol-4-yl)propane-1,3-diol | Jan 26, 2017 | Issued |
Array
(
[id] => 11820476
[patent_doc_number] => 20170209413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'USE OF ASPARAGUSIC ACID AND DERIVATIVES THEREOF TO TREAT SYMPTOMS AND DISORDERS OF NEUROLOGICAL DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/416450
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4375
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15416450
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/416450 | USE OF ASPARAGUSIC ACID AND DERIVATIVES THEREOF TO TREAT SYMPTOMS AND DISORDERS OF NEUROLOGICAL DISEASE | Jan 25, 2017 | Abandoned |
Array
(
[id] => 14518989
[patent_doc_number] => 10336741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases
[patent_app_type] => utility
[patent_app_number] => 15/412505
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29746
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 580
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15412505
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/412505 | Substituted pyrrolidines as factor XIa inhibitors for the treatment thromboembolic diseases | Jan 22, 2017 | Issued |